R. Huber (Munich, Germany), G. Hardavella (Athens, Greece)
This session is built from abstracts published on the ERS Congress platform from 23 August, in a PowerPoint format with a pre-recorded audio narration. The live session is scheduled from September 5-7 and each presenter will have a 5-minutes live, slide show presentation followed at the end of the session by 30-minutes general discussion.
This session includes the Best Abstract for Assembly 11.01 - Lung cancer, entitled "Spirometry and under-diagnosis of COPD in a lung cancer screening cohort”
Spirometry and under-diagnosis of COPD in a lung cancer screening cohort
C. Bradley (Leeds, United Kingdom), M. Kennedy (Leeds, United Kingdom), A. Boland (Leeds, United Kingdom), D. Ellames (Leeds, United Kingdom), D. Dimov (Leeds, United Kingdom), R. Gabe (London, United Kingdom), P. Alexandris (London, United Kingdom), P. Crosbie (Manchester , United Kingdom), M. Callister (Leeds, United Kingdom)
|    |
Application of breathomics in early detection of lung cancer in indian population: a pilot study
B. Pattnaik (New Delhi, India), R. Vadala (New Delhi, India), S. Bangaru (New Delhi, India), N. Bhatraju (New Delhi, India), J. Tak (New Delhi, India), D. Rai (New Delhi, India), S. Kashyap (New Delhi, India), U. Verma (New Delhi, India), H. Iyer (New Delhi, India), R. Guleria (New Delhi, India), A. Agrawal (New Delhi, India), A. Mohan (New Delhi, India)
| |
Validation of lung nodule detection a year before diagnosis in NLST dataset based on a deep learning system
B. Audelan (Sophia-Antipolis, France), S. Lopez (Nice, France), P. Fillard (Paris, France), Y. Diascorn (Nice, France), B. Padovani (Nice, France), H. Delingette (Sophia-Antipolis, France)
| |
Clinical and molecular analysis of lung cancer associated with fibrosing and diffuse interstitial lung disease.
V. Heluain (Toulouse, France), G. Prévot (Toulouse, France), B. Cabarrou (Toulouse, France), O. Calvayrac (Toulouse, France), E. Clermont (Toulouse, France), A. Didier (Toulouse, France), J. Milia (Toulouse, France), J. Mazières (Toulouse, France)
| |
Instant on-site histological feedback on bronchoscopic biopsies using higher harmonic generation microscopy
L. Van Huizen (Amsterdam, Netherlands), J. Daniels (Amsterdam, Netherlands), T. Radonic (Amsterdam, Netherlands), J. Annema (Amsterdam, Netherlands), M. Groot (Amsterdam, Netherlands)
| |
LSC - 2021 - cAMP response element-binding protein mediates immune-evasion of KRAS-mutant lung adenocarcinoma
G. Georgia A., G. Ntaliarda (ntaliarda@upatras.gr / Department of Physiology, F. of Medicine, U. of Patras, ,. , A. ?arazioti (amarazioti@upatras.gr / Department of Physiology, F. of Medicine, U. of Patras, ,. , I. Lilis (ioannislilis@upatras.gr / Department of Physiology, F. of Medicine, U. of Patras, ,. , N. Spiropoulou (nispiropoulou@gmail.com / Department of Physiology, F. of Medicine, U. of Patras, ,. , F. Kalogianni (kalogianni@upatras.gr / Department of Physiology, F. of Medicine, U. of Patras, ,. , E. Tourkochristou (bio3557@upnet.gr / Department of Physiology, F. of Medicine, U. of Patras, ,. , I. Giopanou (giopanou@upatras.gr / Department of Physiology, F. of Medicine, U. of Patras, ,. , M. Spella (magsp@upatras.gr / Department of Physiology, F. of Medicine, U. of Patras, ,. , M. Iliopoulou (marianthi0707@hotmail.com / Department of Physiology, F. of Medicine, U. of Patras, ,. , A. Korfiati (a.korfiati@insybio.com / InSyBio Ltd; Winchester, H. , S. 8SR; United Kingdom,London), K. Theofilatos (k.theofilatos@insybio.co.uk / InSyBio Ltd; Winchester, H. , S. 8SR; United Kingdom,London), S. Mavroudi (s.mavroudi@insybio.co.uk / InSyBio Ltd; Winchester, H. , S. 8SR; United Kingdom,London), T. Mantamadiotis (theo.mantamadiotis@unimelb.edu.au / Cancer Signaling Laboratory, D. of Pathology; University of Melbourne,Melbourne), T. Goldmann (tgoldmann@fz-borstel.de / Clinical and Experimental Pathology, R. Center Borstel; Airway Research Center North (ARCN); Borstel,Borstel), S. Marwitz (smarwitz@fz-borstel.de / Clinical and Experimental Pathology, R. Center Borstel; Airway Research Center North (ARCN); Borstel,Borstel), G. T. Stathopoulos (stathopoulos@helmholtz-muenchen.de / Comprehensive Pneumology Center, H. Center Munich,Munich)
| |
LSC - 2021 - Mutational RNA signatures in environmentally-induced lung adenocarcinoma
G. Georgia A., S. J. Behrend (sabine.behrend@helmholtz-muenchen.de / Comprehensive Pneumology Center, H. Center ,Munich), G. Ntaliarda (ntaliarda@upatras.gr / Department of Physiology, F. of Medicine, U. of Patras,Patras), A. Lamort (anne-sophie.lamort@helmholtz-muenchen.de / Comprehensive Pneumology Center, H. Center ,Munich), M. A.A. Pepe (mario.pepe1985@libero.it / Comprehensive Pneumology Center, H. Center ,Munich), I. Lilis (ioannislilis@upatras.gr / Department of Physiology, F. of Medicine, U. of Patras,Patras), M. Spella (magsp@upatras.gr / Department of Physiology, F. of Medicine, U. of Patras,Patras), G. T. Stathopoulos (stathopoulos@helmholtz-muenchen.de / Comprehensive Pneumology Center, H. Center ,Munich)
| |
The predictive value of circulating tumor DNA dynamics in plasma of EGFR-mutation-positive NSCLC patients on first line tyrosine kinase inhibitors
A. Szpechcinski (Warsaw, Poland), M. Bryl (Poznan, Poland), G. Czyzewicz (Krakow, Poland), E. Wojda (Warsaw, Poland), D. Swiniuch (Poznan, Poland), M. Szwiec (Zielona Gora, Poland), R. Ramlau (Poznan, Poland), P. Sliwinski (Warsaw, Poland), A. Barinow-Wojewodzki (Poznan, Poland), J. Chorostowska-Wynimko (Warsaw, Poland)
| |
Identification of predictive biomarkers of immunotherapy response in non-small cell lung cancer by multiparametric analysis
J. Ramos Paradas (Madrid, Spain), D. Gomez-Sanchez (Madrid, Spain), A. Rosado (Madrid, Spain), I. Ferrer (Madrid, Spain), N. Carrizo (Madrid, Spain), A. Enguita (Madrid, Spain), M. Muñoz (Madrid, Spain), L. Paz-Ares (Madrid, Spain), E. Garrido-Martin (Madrid, Spain)
| |
Late Breaking Abstract - Randomized phase III study of erlotinib compared to intercalated erlotinib with cisplatin and pemetrexed as first-line therapy for advanced EGFR mutated non-small cell lung cancer, the NVALT 17 study.
R. Gijtenbeek (Leeuwarden, Netherlands), V. Van Noort (Leeuwarden, Netherlands), J. Aerts (Rotterdam, Netherlands), J. Staal - Van Den Brekel (Almelo / Hengelo, Netherlands), E. Smit (Amsterdam, Netherlands), F. Krouwels (Hoofddorp, Netherlands), F. Wilschut (Ede, Netherlands), T. Hilterman (Groningen, Netherlands), W. Timens (Groningen, Netherlands), E. Schuuring (Groningen, Netherlands), J. Janssen (Endhoven / Veldhoven, Netherlands), M. Goosens (Zutphen, Netherlands), P. Van De Berg (Willemstad, Curaçao), A. De Langen (Amsterdam, Netherlands), J. Stigt (Zwolle, Netherlands), B. Van Den Borne (Eindhoven, Netherlands), H. Groen (Groningen, Netherlands), W. Van Geffen (Leeuwarden, Netherlands), A. Van Der Wekken (Groningen, Netherlands)
| |
Discussion
| |